280 related articles for article (PubMed ID: 38818286)
1. Unraveling the relationship between histone methylation and nonalcoholic fatty liver disease.
Xu L; Fan YH; Zhang XJ; Bai L
World J Hepatol; 2024 May; 16(5):703-715. PubMed ID: 38818286
[TBL] [Abstract][Full Text] [Related]
2. Histone Methylation Regulation as a Potential Target for Non-alcoholic Fatty Liver Disease.
Liu Y; Chen M
Curr Protein Pept Sci; 2023; 24(6):465-476. PubMed ID: 37246318
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic association study uncovered H3K27 acetylation enhancers and dysregulated genes in high-fat-diet-induced nonalcoholic fatty liver disease in rats.
Ma J; You D; Chen S; Fang N; Yi X; Wang Y; Lu X; Li X; Zhu M; Xue M; Tang Y; Wei X; Huang J; Zhu Y
Epigenomics; 2022 Dec; 14(23):1523-1540. PubMed ID: 36851897
[No Abstract] [Full Text] [Related]
4. Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease.
Li YY
World J Gastroenterol; 2012 Dec; 18(45):6546-51. PubMed ID: 23236228
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease.
Aggeletopoulou I; Kalafateli M; Tsounis EP; Triantos C
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629043
[TBL] [Abstract][Full Text] [Related]
6. Dietary Patterns Influence Target Gene Expression through Emerging Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease.
Zaiou M; Amrani R; Rihn B; Hajri T
Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572442
[TBL] [Abstract][Full Text] [Related]
7. A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progression.
Ramezani M; Zobeiry M; Abdolahi S; Hatami B; Zali MR; Baghaei K
Pathol Res Pract; 2023 Nov; 251():154809. PubMed ID: 37797383
[TBL] [Abstract][Full Text] [Related]
8. Histone Modifications in NAFLD: Mechanisms and Potential Therapy.
Shi Y; Qi W
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834101
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome Proliferator-Activated Receptor-γ as a Target and Regulator of Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease.
Zaiou M
Cells; 2023 Apr; 12(8):. PubMed ID: 37190114
[TBL] [Abstract][Full Text] [Related]
10. DNA Methylation in Nonalcoholic Fatty Liver Disease.
Hyun J; Jung Y
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143364
[TBL] [Abstract][Full Text] [Related]
11. Epigenetics in non-alcoholic fatty liver disease.
Lee J; Kim Y; Friso S; Choi SW
Mol Aspects Med; 2017 Apr; 54():78-88. PubMed ID: 27889327
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic Regulation of Peroxisome Proliferator-Activated Receptor Gamma Mediates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease.
Hajri T; Zaiou M; Fungwe TV; Ouguerram K; Besong S
Cells; 2021 May; 10(6):. PubMed ID: 34072832
[TBL] [Abstract][Full Text] [Related]
13. Combined Methylation and Transcriptome Analysis of Liver Injury of Nonalcoholic Fatty Liver Disease Induced by High Alcohol-Producing Klebsiella pneumoniae.
Zhang R; Xu Z; Xue G; Feng J; Du B; Gan L; Fan Z; Fu T; Feng Y; Zhao H; Cui J; Yan C; Cui X; Tian Z; Chen J; Yu Z; Yuan J
Microbiol Spectr; 2023 Jun; 11(3):e0532322. PubMed ID: 37022192
[TBL] [Abstract][Full Text] [Related]
14. Potential epigenetic mechanism in non-alcoholic Fatty liver disease.
Sun C; Fan JG; Qiao L
Int J Mol Sci; 2015 Mar; 16(3):5161-79. PubMed ID: 25751727
[TBL] [Abstract][Full Text] [Related]
15. Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease.
Murphy SK; Yang H; Moylan CA; Pang H; Dellinger A; Abdelmalek MF; Garrett ME; Ashley-Koch A; Suzuki A; Tillmann HL; Hauser MA; Diehl AM
Gastroenterology; 2013 Nov; 145(5):1076-87. PubMed ID: 23916847
[TBL] [Abstract][Full Text] [Related]
16. Interplay between early-life malnutrition, epigenetic modulation of the immune function and liver diseases.
Campisano S; La Colla A; Echarte SM; Chisari AN
Nutr Res Rev; 2019 Jun; 32(1):128-145. PubMed ID: 30707092
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota induced epigenetic modifications in the non-alcoholic fatty liver disease pathogenesis.
Tang R; Liu R; Zha H; Cheng Y; Ling Z; Li L
Eng Life Sci; 2024 May; 24(5):2300016. PubMed ID: 38708414
[TBL] [Abstract][Full Text] [Related]
18. Deciphering the role of aberrant DNA methylation in NAFLD and NASH.
Vachher M; Bansal S; Kumar B; Yadav S; Burman A
Heliyon; 2022 Oct; 8(10):e11119. PubMed ID: 36299516
[TBL] [Abstract][Full Text] [Related]
19. Low fat but not soy protein isolate was an effective intervention to reduce nonalcoholic fatty liver disease progression in C57BL/6J mice: monitored by a novel quantitative ultrasound (QUS) method.
Rowles JL; Han A; Miller RJ; Kelly JR; Applegate CC; Wallig MA; O'Brien WD; Erdman JW
Nutr Res; 2019 Mar; 63():95-105. PubMed ID: 30824402
[TBL] [Abstract][Full Text] [Related]
20. Single-Cell Data Analysis Reveals Critical Hepatic Cells Subpopulations in the Progression of Non-alcoholic Fatty Liver Disease to Non-Alcoholic Steatohepatitis.
Zhao C; Ji G; Zhao X; Ma T; Li Y; Wu W; Zhou L
Comb Chem High Throughput Screen; 2024 May; ():. PubMed ID: 38803181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
